Literature DB >> 8609917

Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy.

A M Tjon-A-Tsien1, H H Lemkes, A J van der Kamp-Huyts, J G van Dijk.   

Abstract

Recording site is an important cause of variability of compound muscle action potential (CMAP) and conduction parameters, which can be reduced by using large electrodes. Repeatability of CMAP and conduction parameters of conventional and large electrodes was compared in 16 controls and 17 diabetic neuropathic patients, using defined recording sites linked to anatomical landmarks. Right-sided median, peroneal, and tibial nerves were investigated twice with a 1-2 week interval by the same examiner. Compared to previous studies, conventional electrodes on strictly defined recording sites resulted in better repeatability: intraindividual coefficients of variation (CV) varied between 4% and 14.4% for all parameters. CV of conduction parameters, not published previously, was smaller than CV of CMAP parameters. The use of large electrodes improved repeatability further: large electrodes resulted in substantially smaller CV for duration, amplitude, area, and changes of amplitude and area over a length of nerve, which were reduced by 10%, 31%, 29%, 27%, and 16%, respectively. Patients had higher CV than controls; large electrodes reduced patient CV more than control CV, resulting in less contrast between groups. Strictly defined recording sites and large electrodes improve repeatability of motor conduction studies to relevant degrees: all CMAP and conduction parameters are suitable for longitudinal studies of neuropathic patients.

Entities:  

Mesh:

Year:  1996        PMID: 8609917     DOI: 10.1002/(SICI)1097-4598(199606)19:6<689::AID-MUS1>3.0.CO;2-6

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Comparison of CMT1A and CMT2: similarities and differences.

Authors:  Henriette M E Bienfait; Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Bram W Ongerboer de Visser; Rob J de Haan; Frank Baas; Baziel G M van Engelen; Marianne de Visser
Journal:  J Neurol       Date:  2006-08-28       Impact factor: 4.849

2.  Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia.

Authors:  Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Rob J de Haan; Marinus Vermeulen; Marianne de Visser
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

3.  Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial.

Authors:  Camiel Verhamme; Rob J de Haan; Marinus Vermeulen; Frank Baas; Marianne de Visser; Ivo N van Schaik
Journal:  BMC Med       Date:  2009-11-12       Impact factor: 8.775

4.  Repeatability of nerve conduction measurements using automation.

Authors:  Xuan Kong; Eugene A Lesser; J Thomas Megerian; Shai N Gozani
Journal:  J Clin Monit Comput       Date:  2006-09-14       Impact factor: 2.502

5.  Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.

Authors:  Johanna C M Schilder; J Gert van Dijk; Dirk Dressler; Johannes H T M Koelman; Johan Marinus; Jacobus J van Hilten
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

6.  Assessing Rat Forelimb and Hindlimb Motor Unit Connectivity as Objective and Robust Biomarkers of Spinal Motor Neuron Function.

Authors:  Markus E Harrigan; Angela R Filous; Andrew P Tosolini; Renee Morris; Jan M Schwab; W David Arnold
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

7.  Anterior shin muscles CMAP measurements: Normal limits of symmetry and intra- and interobserver reliability.

Authors:  Jan Willems; Thomas Mathieu; Dagmar Gorissen
Journal:  Clin Neurophysiol Pract       Date:  2021-02-15

8.  Repeatability of nerve conduction measurements derived entirely by computer methods.

Authors:  Xuan Kong; Eugene A Lesser; Shai N Gozani
Journal:  Biomed Eng Online       Date:  2009-11-06       Impact factor: 2.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.